AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimkar-M 3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Care Formulation Labs Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glimkar-M 3 Tablet SR

Diabetam-Duo 3 Extended-Release tablets are antidiabetic medications combining two agents for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. Always take Diabetam-Duo 3 ER with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify hypoglycemic symptoms (sweating, dizziness, headache, tremors) and implement appropriate countermeasures. Maintain regular mealtimes and always carry a fast-acting glucose source like candy or juice. Alcohol consumption raises hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use Diabetam-Duo 3 ER if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Inform your physician of any prior heart conditions before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring is essential; additional blood tests to check blood cell counts and liver function may be recommended by your doctor.

Uses of Glimkar-M 3 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimkar-M 3 Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimkar-M 3 Tablet SR with food.

Common Side effects of Glimkar-M 3 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimkar-M 3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glimkar-M 3 Tablet SR should be administered with a meal.

How Glimkar-M 3 Tablet SR works:

Glimkar-M 3 SR tablets contain a dual-action antidiabetic formula: glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimkar-M 3 Tablet SR and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimkar-M 3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimkar-M 3 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimkar-M 3 SR tablets cautiously, potentially requiring dosage modification under medical supervision. Glimkar-M 3 SR tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimkar-M 3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimkar-M 3 Tablet SR :

Should you forget to take a Glimkar-M 3 Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimkar-M 3 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimkar-M 3 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimkar-M 3 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimkar-M 3 Tablet SR and seek immediate medical attention.
Glimkar-M 3 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for treating type 1 DM.
Glimkar-M 3 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimkar-M 3 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental Vitamin B12 is recommended annually by some researchers.
Glimkar-M 3 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimkar-M 3 Tablet SR and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimkar-M 3 Tablet SR
73
MRP 89
17% off